ConductScience.org, home

Paper30833429

Revising Pediatric Vancomycin Dosing Accounting for Nephrotoxicity in a Pharmacokinetic-Pharmacodynamic Model.

Kloprogge F and 6 others. Antimicrob Agents Chemother, 2019. Cited by 32 papers, by iCite.

Cite this record

ConductScience Library. Revising Pediatric Vancomycin Dosing Accounting for Nephrotoxicity in a Pharmacokinetic-Pharmacodynamic Model. Papers, record 30833429. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30833429

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Revising Pediatric Vancomycin Dosing Accounting for Nephrotoxicity in a Pharmacokinetic-Pharmacodynamic Model.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
2019
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
32
iCite
Relative citation ratio, by iCite
2.47
iCite
Revised in PubMed
2025-05-30
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kloprogge FFrankhttps://orcid.org/0000-0001-7213-4559
2Hill LFLouise F
3Booth JJohn
4Klein NNigel
5Irwin ADAdam D
6Dixon GGarth
7Standing JFJoseph F

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
VancomycinMajor topic
Child
Child, Preschool
Female
Humans
Infant
Infant, Newborn
Logistic Models
Male
Microbial Sensitivity Tests
Multivariate Analysis

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
MR/M008665/1Medical Research CouncilUnited KingdomPubMed
MR/P014534/1Medical Research CouncilUnited KingdomPubMed

Source PubMed

Download CSV of grants

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128474732The Nephrotoxicity of Vancomycin.Clin Pharmacol Ther2017https://conductscience.org/library/papers/28474732PubMed
227270281Development and Evaluation of a Gentamicin Pharmacokinetic Model That Facilitates Opportunistic Gentamicin Therapeutic Drug Monitoring in Neonates and Infants.Antimicrob Agents Chemother2016https://conductscience.org/library/papers/27270281PubMed
320385872Population pharmacokinetics of vancomycin in premature Malaysian neonates: identification of predictors for dosing determination.Antimicrob Agents Chemother2010https://conductscience.org/library/papers/20385872PubMed
418846389Human renal function maturation: a quantitative description using weight and postmenstrual age.Pediatr Nephrol2009https://conductscience.org/library/papers/18846389PubMed
527999035Impact of vancomycin protein binding on target attainment in critically ill children: back to the drawing board?J Antimicrob Chemother2017https://conductscience.org/library/papers/27999035PubMed
627767204Scaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful?Br J Clin Pharmacol2017https://conductscience.org/library/papers/27767204PubMed
726582878Pharmacodynamic Characteristics of Nephrotoxicity Associated With Vancomycin Use in Children.J Pediatric Infect Dis Soc2015https://conductscience.org/library/papers/26582878PubMed
826953202Vancomycin 24-Hour Area under the Curve/Minimum Bactericidal Concentration Ratio as a Novel Predictor of Mortality in Methicillin-Resistant Staphylococcus aureus Bacteremia.Antimicrob Agents Chemother2016https://conductscience.org/library/papers/26953202PubMed
923420517Population pharmacokinetics of tobramycin in patients with and without cystic fibrosis.Clin Pharmacokinet2013https://conductscience.org/library/papers/23420517PubMed
1025998107Predictive Performance of a Vancomycin Population Pharmacokinetic Model in Neonates.Infect Dis Ther2015https://conductscience.org/library/papers/25998107PubMed
1129285245A population pharmacokinetic model for individualised dosage regimens of vancomycin in Chinese neonates and young infants.Oncotarget2017https://conductscience.org/library/papers/29285245PubMed
1227884052Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics.CPT Pharmacometrics Syst Pharmacol2017https://conductscience.org/library/papers/27884052PubMed
1327631462Pediatric Patients With Solid or Hematological Tumor Disease: Vancomycin Population Pharmacokinetics and Dosage Optimization.Ther Drug Monit2016https://conductscience.org/library/papers/27631462PubMed
1424579085Serum and urinary NGAL in septic newborns.Biomed Res Int2014https://conductscience.org/library/papers/24579085PubMed
1521217178Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.Clin Infect Dis2011https://conductscience.org/library/papers/21217178PubMed
1615509186Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections.Clin Pharmacokinet2004https://conductscience.org/library/papers/15509186PubMed
1729675639Pharmacokinetic-Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance.Clin Pharmacokinet2019https://conductscience.org/library/papers/29675639PubMed
1823340565Improved vancomycin dosing in children using area under the curve exposure.Pediatr Infect Dis J2013https://conductscience.org/library/papers/23340565PubMed
1923439463Pediatric Risk, Injury, Failure, Loss, End-Stage renal disease score identifies acute kidney injury and predicts mortality in critically ill children: a prospective study.Pediatr Crit Care Med2013https://conductscience.org/library/papers/23439463PubMed
2024663023Population pharmacokinetics and dosing optimization of vancomycin in children with malignant hematological disease.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/24663023PubMed

See all 36 referencesDownload CSV of references

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.

PMIDTitleJournalYearIn PapersSource
42792002Vancomycin AUC24 Estimation for Children with Bayesian Forecasting and First-Order Equations to Update Dose Recommendations.Antibiotics (Basel)2026https://conductscience.org/library/papers/42792002PubMed
42750196Multisite Analysis of Vancomycin Concentration Predictions in a Bayesian Software in Adult and Pediatric Patients With and Without Acute Kidney Injury.Pharmacotherapy2026https://conductscience.org/library/papers/42750196PubMed
42508420Population Pharmacokinetic and Exposure-Response Analysis of Vancomycin Nephrotoxicity in Cystic Fibrosis Patients.Pediatr Pulmonol2026https://conductscience.org/library/papers/42508420PubMed
42387116Impact of Febrile State on Vancomycin Clearance in Pediatric Patients: Insights From Population Pharmacokinetic Modeling.Pharm Res2026https://conductscience.org/library/papers/42387116PubMed
42183861Case report: Delayed onset rash, delirium, and cross allergic reactions caused by sequential administration of cefoperazone sulbactam, meropenem, and piperacillin tazobactam.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/42183861PubMed
42118093Model-informed precision dosing of vancomycin in children 3 months to 18 years of age using Australia-wide data.Antimicrob Agents Chemother2026https://conductscience.org/library/papers/42118093PubMed
42082885Precision Dosing of Vancomycin: A Systematic Review of Population Pharmacokinetics Models and Comparative Evaluation of Software Tools.Clin Pharmacokinet2026https://conductscience.org/library/papers/42082885PubMed
41873632Systematic review and scoring-based selection of pharmacokinetic models for precision dosing of vancomycin in neonates and children.Br J Clin Pharmacol2026https://conductscience.org/library/papers/41873632PubMed
41015987Pharmacodynamics of Vancomycin Against Coagulase-Negative Staphylococci Bloodstream Infections.Pharmacol Res Perspect2025https://conductscience.org/library/papers/41015987PubMed
41001338Pharmacovigilance practice on off-label high-dose of vancomycin in severely ill children.Front Pharmacol2025https://conductscience.org/library/papers/41001338PubMed
39903655Prediction of Vancomycin Area Under the Curve With Trough Concentrations Only: Performance Evaluation of Pediatric Population Pharmacokinetic Models.J Infect Dis2025https://conductscience.org/library/papers/39903655PubMed
36471223Pilot Pharmacokinetic Study in Healthy Adults Using Intravascular Microdialysis Catheters Modified for Use in Paediatric Patients to Assess Vancomycin Blood Levels.Clin Pharmacokinet2023https://conductscience.org/library/papers/36471223PubMed
36404388Evaluation of Neonatal and Paediatric Vancomycin Pharmacokinetic Models and the Impact of Maturation and Serum Creatinine Covariates in a Large Multicentre Data Set.Clin Pharmacokinet2023https://conductscience.org/library/papers/36404388PubMed
36091788Pharmacokinetic assessment of vancomycin in critically ill patients and nephrotoxicity prediction using individualized pharmacokinetic parameters.Front Pharmacol2022https://conductscience.org/library/papers/36091788PubMed
35845555Population Pharmacokinetics and Pharmacodynamics of Vancomycin in Pediatric Patients With Various Degrees of Renal Function.J Pediatr Pharmacol Ther2022https://conductscience.org/library/papers/35845555PubMed
34750740Pharmacokinetics of Vancomycin in Critically Ill Children: A Systematic Review.Eur J Drug Metab Pharmacokinet2022https://conductscience.org/library/papers/34750740PubMed
34671937An Update on Population Pharmacokinetic Analyses of Vancomycin, Part II: In Pediatric Patients.Clin Pharmacokinet2022https://conductscience.org/library/papers/34671937PubMed
34484661Changes of renal transporters in the kinetic process of VCM-induced nephrotoxicity in mice.Toxicol Res (Camb)2021https://conductscience.org/library/papers/34484661PubMed
34002357Population Pharmacokinetic Models of Vancomycin in Paediatric Patients: A Systematic Review.Clin Pharmacokinet2021https://conductscience.org/library/papers/34002357PubMed
33466764Amikacin or Vancomycin Exposure Alters the Postnatal Serum Creatinine Dynamics in Extreme Low Birth Weight Neonates.Int J Environ Res Public Health2021https://conductscience.org/library/papers/33466764PubMed

See all 23 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30833429

GET https://conductscience.org/api/papers/v1/30833429/references?page=2